Physiologically-Based Pharmacokinetic Modeling of the Drug-Drug Interaction of the UGT Substrate Ertugliflozin Following Co-Administration with the UGT Inhibitor Mefenamic Acid.
CPT Pharmacometrics Syst Pharmacol
; 10(2): 127-136, 2021 02.
Article
in En
| MEDLINE
| ID: mdl-33314761
Full text:
1
Database:
MEDLINE
Main subject:
Mefenamic Acid
/
Cyclooxygenase Inhibitors
/
Glucuronosyltransferase
/
Bridged Bicyclo Compounds, Heterocyclic
/
Sodium-Glucose Transporter 2 Inhibitors
Type of study:
Prognostic_studies
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
CPT Pharmacometrics Syst Pharmacol
Year:
2021
Type:
Article
Affiliation country:
United States